"Migraine headache is considered the most costly brain disorder in the United States," said Russ Mitchell, the Chairman and CEO of PuraMed BioScience. "It costs the economy over $50 billion in treatment costs as well as lost productivity ... with an average loss of 157 million workdays."

Migraines also have an effect on service men and women. According to Mitchell, veterans coming back from combat are twice as likely to develop migraines than the normal population.

When asked how LipiGesic M was different than other products including vasodilators, Mitchell responded, "Based on our results, it is as effective, if not more effective, than the leading prescription drug ... you don't need a prescription ... it is actually faster because it is a gel that you put under your tongue ... it is very safe ... and has a very low cost compared to even the generic prescription drugs."

LipiGesic M is currently available in CVS and Walgreen's stores nationwide.

Big Biz ShowBig Biz Show hosted by Bob "Sully" Sullivan with Russ T. Nailz is a nationally syndicated radio / television program broadcast on 150 stations throughout the country with a weekly reach of 1.7 million listeners. Big Biz Show also can be found on Internet sites via the Business Talk Radio Network (BTRN) that includes CBS Radio, Yahoo Radio, AOL Radio and others. The Big Biz Show is also aired on Armed Forces Radio and on the WeathTV Network.

The Big Biz Show is acclaimed by the Wall Street Journal and has been named in the top ten financial radio talk shows by Talkers magazine. For more information about Big Biz Show go to http://bigbizshow.com/.

About PuraMed BioScience, Inc.PuraMed BioScience® engages in the research, development, and marketing of non-prescription medicinal and healthcare products. In addition to LipiGesic® M, www.lipiGesic.com, PuraMed BioScience plans to launch LipiGesic® H for tension-type headaches and LipiGesic® PM, which provides a remedy for insomnia and other sleep disorders. For more information visit: www.puramedbioscience.com.

Forward-Looking StatementsThis news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties that may cause actual results and future achievements of PuraMed BioScience to be materially different from those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.